Search

Your search keyword '"Shimada, Hiromi"' showing total 19 results
Start Over Author "Shimada, Hiromi" Publication Year Range Last 3 years
19 results on '"Shimada, Hiromi"'

10. Colchicine-responsive chronic recurrent multifocal osteomyelitis associated with familial Mediterranean fever in the presence of MEFV mutation: A case report.

Author

Izumikawa, Miharu, Kato, Mikiya, Wakiya, Risa, Kameda, Tomohiro, Nakashima, Shusaku, Shimada, Hiromi, Miyagi, Taichi, Sugihara, Koichi, Ushio, Yusuke, Mino, Rina, Mizusaki, Mao, Chujo, Kanako, Hiraishi, Takashi, Kadowaki, Norimitsu, and Dobashi, Hiroaki

Subjects
FAMILIAL Mediterranean fever, OSTEOMYELITIS, GENETIC mutation, INFORMED consent (Medical law), TRANCE protein
Published
2024
Full Text
View/download PDF

11. Colchicine-responsive chronic recurrent multifocal osteomyelitis associated with familial Mediterranean fever in the presence of MEFV mutation: A case report

Author

Izumikawa, Miharu, primary, Kato, Mikiya, additional, Wakiya, Risa, additional, Kameda, Tomohiro, additional, Nakashima, Shusaku, additional, Shimada, Hiromi, additional, Miyagi, Taichi, additional, Sugihara, Koichi, additional, Ushio, Yusuke, additional, Mino, Rina, additional, Mizusaki, Mao, additional, Chujo, Kanako, additional, Hiraishi, Takashi, additional, Kadowaki, Norimitsu, additional, and Dobashi, Hiroaki, additional

Published
2023
Full Text
View/download PDF

12. Immunological disease activity parameters at conception are risk factors for preterm birth and low birth weight in patients with systemic lupus erythematosus

Author

Shimada, Hiromi, primary, Wakiya, Risa, additional, Kameda, Tomohiro, additional, Nakashima, Shusaku, additional, Miyagi, Taichi, additional, Sugihara, Koichi, additional, Ushio, Yusuke, additional, Mino, Rina, additional, Mizusaki, Mao, additional, Chujo, Kanako, additional, Kanenishi, Kenji, additional, Kadowaki, Norimitsu, additional, and Dobashi, Hiroaki, additional

Published
2023
Full Text
View/download PDF

13. Pregnancy course and outcomes of patients with polymyositis and dermatomyositis (PM/DM) managed in a single center

Author

Mino, Rina, primary, Shimada, Hiromi, additional, Wakiya, Risa, additional, Nakashima, Shusaku, additional, Miyagi, Taichi, additional, Sugihara, Koichi, additional, Ushio, Yusuke, additional, Mizusaki, Mao, additional, Chujo, Kanako, additional, Kameda, Tomohiro, additional, Kanenishi, Kenji, additional, Kadowaki, Norimitsu, additional, and Dobashi, Hiroaki, additional

Published
2023
Full Text
View/download PDF

14. Supplemental material - Immunological disease activity parameters at conception are risk factors for preterm birth and low birth weight in patients with systemic lupus erythematosus

Author

Shimada, Hiromi, Wakiya, Risa, Kameda, Tomohiro, Nakashima, Shusaku, Miyagi, Taichi, Sugihara, Koichi, Ushio, Yusuke, Mino, Rina, Mizusaki, Mao, Chujo, Kanako, Kanenishi, Kenji, Kadowaki, Norimitsu, and Dobashi, Hiroaki

Subjects
111702 Aged Health Care, FOS: Health sciences
Abstract

Supplemental material for Immunological disease activity parameters at conception are risk factors for preterm birth and low birth weight in patients with systemic lupus erythematosus by Hiromi Shimada, Risa Wakiya, Tomohiro Kameda, Shusaku Nakashima, Taichi Miyagi, Koichi Sugihara, Yusuke Ushio, Rina Mino, Mao Mizusaki, Kanako Chujo, Kenji Kanenishi, Norimitsu Kadowaki, and Hiroaki Dobashi in Lupus Journal.

Published
2023
Full Text
View/download PDF

15. Humoral immune response against BNT162b2 mRNA COVID-19 vaccine in patients with rheumatic disease undergoing immunosuppressive therapy: A Japanese monocentric study

Author

Sugihara, Koichi, primary, Wakiya, Risa, additional, Kameda, Tomohiro, additional, Shimada, Hiromi, additional, Nakashima, Shusaku, additional, Kato, Mikiya, additional, Miyagi, Taichi, additional, Ushio, Yusuke, additional, Mizusaki, Mao, additional, Mino, Rina, additional, Chujo, Kanako, additional, Nomura, Yumi, additional, Inoo, Masayuki, additional, Kadowaki, Norimitsu, additional, and Dobashi, Hiroaki, additional

Published
2022
Full Text
View/download PDF

16. Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy

Author

Sugihara, Koichi, primary, Wakiya, Risa, additional, Shimada, Hiromi, additional, Kameda, Tomohiro, additional, Nakashima, Shusaku, additional, Kato, Mikiya, additional, Miyagi, Taichi, additional, Mizusaki, Mao, additional, Mino, Rina, additional, Nomura, Yumi, additional, Inoo, Masayuki, additional, Kadowaki, Norimitsu, additional, and Dobashi, Hiroaki, additional

Published
2022
Full Text
View/download PDF

17. Efficacy and safety of apremilast and its impact on serum cytokine levels in patients with Behçet's disease

Author

Wakiya, Risa, primary, Ushio, Yusuke, additional, Ueeda, Kiyo, additional, Kameda, Tomohiro, additional, Shimada, Hiromi, additional, Nakashima, Shusaku, additional, Kato, Mikiya, additional, Miyagi, Taichi, additional, Sugihara, Koichi, additional, Mizusaki, Mao, additional, Mino, Rina, additional, Kadowaki, Norimitsu, additional, and Dobashi, Hiroaki, additional

Published
2022
Full Text
View/download PDF

18. [18F] FDG uptake in patients with spondyloarthritis: correlation with serum inflammatory biomarker levels.

Author

Manabe, Yuri, Norikane, Takashi, Yamamoto, Yuka, Murao, Mitsumasa, Shimada, Hiromi, Wakiya, Risa, Nakashima, Shusaku, Dobashi, Hiroaki, and Nishiyama, Yoshihiro

Subjects
SPONDYLOARTHROPATHIES, POSITRON emission tomography, BLOOD sedimentation, BIOMARKERS, MATRIX metalloproteinases, POLYETHYLENE terephthalate
Abstract

Background: We aimed to evaluate the correlation between 2-deoxy-2-[18F]fluoro-D-glucose (FDG) uptake and disease activity assessed by serum inflammatory biomarker levels in patients with spondyloarthritis (SpA). Methods: A total of 36 SpA patients (24 untreated and 12 treated) were examined using FDG positron emission tomography (PET)/computed tomography and classified into axial SpA (axSpA) and peripheral SpA (pSpA). FDG uptake was evaluated in 23 regions of the body and scored as follows: 0 = less than liver uptake; 1 = more than or equal to liver uptake; and 2 = more than or equal to twice liver uptake. A score of 1 or 2 was considered positive. The number of positive regions and the total score were counted in each patient. The maximum standardized uptake value (SUVmax) was calculated for each region, and maximum SUVmax (MaxSUVmax) was used as a representative value. Correlation of PET findings with serum inflammatory biomarker levels, including C-reactive protein (CRP), erythrocyte sedimentation rate, and matrix metalloproteinase 3 (MMP-3), was analyzed. Results: All but two patients had at least one positive lesion. PET indices correlated significantly with most of the serum inflammatory biomarker levels in untreated SpA, but not in treated SpA. Further, MaxSUVmax, number of positive regions, and total score correlated significantly with CRP (all P values < 0.001), and the number of positive regions (P = 0.012) and total score (P = 0.007) correlated significantly with MMP-3 in untreated pSpA. PET indices did not correlate with any serum inflammatory biomarker level in untreated axSpA. Conclusion: FDG uptake in untreated pSpA correlated significantly with serum inflammatory biomarker levels. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results